UBE2I and neoplasm: UBE2I is upregulated in OC and linked to poor prognosis; its silencing inhibits tumor aggressiveness and drives M1 macrophage polarization via enhanced glycolysis, which in turn promotes PD-L1 expression. Glycolysis inhibitor reversed UBE2I-mediated M1 polarization.